The Left doesn’t want to admit the damage cannabis can do to the mind
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
25 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 25 separate news trends connected to Health Policy, spanning June 19, 2026 through October 1, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 181 article observations and 173 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
University of Liverpool’s two‑year trial finds diet drinks perform like water for weight loss, prompting health‑policy discussion
Former House majority leader Eric Cantor jumps to the top of pharma lobbying as PhRMA’s new CEO, turning Capitol experience into industry muscle.
GLP‑1 hype meets science as demand spikes, safety debates and efficacy doubts flood the media
A surge in colorectal cancer among adults under 45 is reshaping screening policies worldwide.
Illinois expands its medical cannabis program to include two new qualifying conditions
SNAP recipients are buying less soda, but the policy change has unintended consequences.
The Trump administration is signaling potential changes to the childhood vaccine schedule, sparking debate and concern among health professionals and parents.
Florida is moving to repeal four required vaccines for schoolchildren, sparking debate and political maneuvering.
Public health guidance undergoes transition as the administration initiates a review of federal vaccine recommendations following an executive order.
A shadow medical system is emerging as AI diagnostic tools bypass traditional patient outcome testing.
Men over 50 in the UK will no longer be automatically entitled to prostate cancer blood tests.
Two non-smokers, an 11-year-old girl and a 38-year-old woman, have been diagnosed with stage 4 lung cancer.
Proposed changes to testosterone therapy guidelines spark debate on who truly needs the hormone.
Global health systems face a reconfiguration of HIV response strategies following an adjustment to United States aid policy.
Ancient plagues are resurfacing in the wake of Trump's public health cuts.
One in eight U.S. adults now utilizes GLP-1 drugs as Medicare expands coverage for weight-loss treatments.
An FDA advisory committee has voted to add six peptides to a drug compounding list, sparking debate over regulatory standards and future access.
An FDA advisory panel has voted in favor of easing access to peptides, signaling a potential shift in regulatory policy for the substances.
The FDA is convening an advisory panel to evaluate seven peptide injections amid increased public interest and pressure regarding existing regulatory restrictions.
Testosterone replacement therapy is the latest focus of MAGA supporters, sparking debate and policy discussions.
A new generation of Alzheimer’s drug treatments has entered the spotlight, promising potential to halt the disease before symptoms manifest.
Ontario joins Quebec in lowering the age for colorectal cancer screening to 45, sparking debate on testing methods.
The World Health Organization is pushing for expanded newborn screening to detect birth defects early.
The Trump administration is pushing to ease restrictions on testosterone replacement therapy.